文献リスト

1) 大腸癌研究会. 大腸癌治療ガイドライン. 大腸癌研究会, 編. 2009年版. 東京: 金原出版; 2009

2) 杉原健一. Stage IV 大腸癌の治療方針はどう変わったか. 外科治療. 2007; 96: 979-83

3) Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastasis colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996; 224: 509-22

4) Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a north central cancer treatment group phaseII study. J Clin Oncol. 2005; 23: 9243-9

5) Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol. 2006; 13: 58-65

6) 加藤知行, 平井 孝, 清水康博, 他. 肝転移を伴うStage IV 大腸癌の治療方針. 外科治療. 2007; 96: 984-91

7) Temple LK, Hsieh L, Wong WD, et al. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol. 2004; 22: 3475-84

8) National Comprehensive Cancer Network. NCCN clinical practice guideline in oncology. Rectal cancer-v.1.2008. http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf

9) Law WL, Chan WF, Lee YM, et al. Non-curative surgery for colorectal cancer: critical appraisal of outcomes. Int J Colorectal Dis. 2004; 19: 197-202

10) Konyalian VR, Rosing DK, Haukoos JS, et al. The role of primary tumour resection in patients with stage IV colorectal cancer. Colorectal Dis. 2007; 9: 430-7

11) Sarela AI, Guthrie JA, Seymour MT, et al. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg. 2001; 88: 1352-6

12) Muratore A, Zorzi D, Bouzari H, et al. Asymptomatic colorectal cancer with un-resectable liver metastasis: Immediate colorectal resection or up-front systemic chemotherapy？ Ann Surg Oncol. 2006; 14: 766-70

13) Mentha G, Majno PE, Andres A, et al. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastasis before treatment of the primary. Br J Surg. 2006; 93: 872-8

14) 高橋慶一, 山口達郎, 松本 寛, 他. 切除不能遠隔転移を有する患者に対する原発巣切除の方針. 大腸癌Frontier. 2008; 1: 274-7

15) Rodgers MS, McCAll JL. Surgery for colorectal liver metastasis with hepatic lymphnode involvement: a systematic review. Br J Surg. 2000; 87: 1142-55

16) Martin LW, Warren RS. Current management of colorectal liver metastases. Surg Oncol Clin N Am. 2000; 9: 853-76

17) Penna C, Nordlinger B. Colorectal metastasis(liver and lung). Surg Clin N Am. 2002; 82: 1075-90

18) Choti MA, Bowman HM, Pitt HA, et al. Should hepatic resections be performed at high-volume referral centers？ J Gastrointest Surg. 1998; 2: 11-20

19) Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003; 138: 1198-206

20) 山元謙太郎, 橋本拓哉, 背山泰治, 他. 肝転移の治療方針 外科治療. 大腸癌Frontier. 2008; 1: 278-85

21) Weber SM, Jarnagin WR, Dematteo RP, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol. 2000; 7: 643-50

22) Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003; 46: 22-31

23) 大腸癌研究会. 大腸癌治療ガイドライン. 大腸癌研究会, 編. 2005年版. 東京: 金原出版; 2005

24) 高橋慶一, 松本 寛, 山口達郎, 他. 大腸癌肝転移に対する肝切除後の評価. 外科. 2008; 70: 843-50

25) Yamamoto J, Shimada K, Kosuge T, et al. Factors influencing survival of patients undergoing hepatectomy for colorectal metastasis. Br J Surg. 1999; 86: 232-337

26) Yamamoto J, Sugihara K, Kosuge T, et al. Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg. 1995; 221: 74-8

27) Kokudo N, Tada K, Seki M, et al. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg. 2001; 181: 153-9

28) 山本順司, 齊浦明夫, 古賀倫太郎, 他. 大腸癌肝転移における切除断端の意義. 外科. 2004; 66: 1615-22

29) Fortner JG, Silva JS, Golbey RB, et al. Multivariate analysis of hepatic metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 1984; 199: 306-16

30) Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of pattern of recurrence. Surgery. 1986; 100: 278-84

31) Ekberg H, Tranberg KG, Andersson R, et al. Pattern of recurrence in liver resection for colorectal secondaries. World J Surg. 1987; 11: 541-7

32) Nordinger B, Jaeck D, Guiguet M, et al. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery In: Nordinger B, Jaeck D, editors. Treatment of hepatic metastases of colorectal cancer. Paris: Springer-Verlag; 1992. p. 129-46

33) Cady B, Jenkins RL, Steele Jr GD, et al. Surgical margin in hepatic resection for colorectal metastases: a critical and improvable determinant of outcome. Ann Surg. 1998; 227: 566-71

34) Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on surviving and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005; 241: 715-24

35) Hamady ZZR, Cameron IC, Wyatt J, et al. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis; a critical appraisal of the 1cm rule. EJSO. 2006; 32: 557-63

36) Kokudo N, Miki Y, Sugai S, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002; 137: 833-40

37) Beckurts KTE, Hoelscher AH, Thorban ST, et al. Significance of lymph node imvolvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg. 1997; 84: 1081-4

38) Nakamura S, Suzuki S, Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years' experience. J Hepatobiliary Pancreat Surg. 1999; 6: 16-22

39) Jaeck D, Nakano H, Bachellier P, et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastase: a prospective study. Ann Surg Oncol. 2002; 9: 430-8

40) Elias D, Ouellet JF, Bellon N, et al. Extrahepatic disease dose not contraindicate hepatectomy for colorectal liver metastases. Br J Surg. 2003; 90: 567-74

41) Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver; a prognostic scoring system to improve case selection, based on 1568 patients; Association Francaise de Chirurgie. Cancer. 1996; 77: 1254-62

42) 上野秀樹, 橋口陽二郎, 初瀬一夫, 他. 大腸癌肝転移に対する wait-and-see policy. 外科. 2004; 66: 1605-9

43) Ueno H, Mochizuki H, Hatsuse K, et al. Indicators for treatment strategies of colorectal liver metastases. Ann Surg. 2000; 231: 59-66

44) Lambert L, Colacchio T, Barth R. Interval hepatic resection of colorectal metastases improves patients selection. Arch Surg. 2000; 135: 473-80

45) 安野正道, 杉原健一. 大腸癌肝転移の治療戦略; 切除の適応と肝切除時期; 肝切除はいつ行うか. 胆と膵. 2005; 26: 291-7

46) Capussotti L, Vigano L, Ferrero A, et al. Timing of resection of liver metastases synchronous to colorectal tumor; Proposal of prognosisi-based decisional model. Ann Surg Oncol. Epub 2007; 14: 1143-50

47) 緒方 裕, 白水和雄. 肝転移の治療─熱凝固療法. 杉原健一, 編. 再発大腸癌治療カイドブック. 東京: 南江堂; 2003. p. 107

48) 鈴木昌八, 坂口孝宣, 中村 達. 肝切除後の残肝再発に対する治療. 外科. 2004; 66: 1666-70

49) Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer; a pilot clinical study. Am J Gastroenterol. 1999; 94: 322-7

50) Lubienski A. Radiofrequency ablation in metastatic disease. Recent Results in Cancer Research. 2005; 165: 268-76

51) Abitabile O, Hartl U, Lange J, et al. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. EJSO. 2007; 33: 67-71

52) Curley SA. Outcomes after surgical treatment of colorectal cancer liver metastases. Semin Oncol. 2005; 32(suppl): S109-11

53) Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases. Invest Radiol. 2004; 39: 689-97

54) Machi J, Oishi AJ, Sumida K, et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer; Evaluation of prognostic factors and effectiveness in first-and second line management. Cancer J. 2006; 12: 318-26

55) Amersi FF, McElrath-Garza A, Ahmad A, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg. 2006; 141: 581-8

56) Park IJ, Kim HC, Yu CS, et al. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol. 2008; 15: 227-32

57) 荒井保明, 竹内義人. 肝転移の治療方針 動注化学療法. 大腸癌Frontier. 2008; 1: 286-91

58) Decreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol. 2005; 23: 4881-7

59) Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2005; 23: 4888-96

60) Sato Y, Muro K, Inaba Y, et al. Is hepatic arterial infusion of 5FU flowed by systemic chemotherapy superior to systemic chemotherapy alone for unresectable severe liver metastases from colorectal cancer. Proc ASCO-GI symposium. 2009(Personal communication)

61) 岡 正朗, 内山哲史, 森近博史, 他. 腹膜播種を伴う大腸癌症例の臨床病理学的検討—肝転移例との比較—. 日臨外医会誌. 1993; 2535-9

62) Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis comparison of concomitant vs. delayed management. Dis Colon Rectum. 2000; 43: 1341-8

63) 平井 孝, 加藤知行, 金光幸秀. 大腸癌腹膜播種性転移の治療とその成績. 外科. 2004; 66: 921-5

64) 山口由美, 柴田俊輔, 石黒 稔, 他. 腹膜播種を伴う大腸癌切除例の臨床病理学的検討. 臨床外科. 2004; 59: 181-6

65) Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006; 243: 212-22

66) Sugarbaker PH, Schellinx ME, Chang D, et al. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg. 1996; 20: 585-91

67) Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995; 221: 29-42

68) 米村 豊, 池野龍雄, 新保雅也, 他. 腹膜播種に対する腹膜切除の治療成績. 癌と化学療法. 2007; 34: 1926-30

69) Verwaal VJ, Ruth S, Witkamp, et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005; 12: 65-71

70) Yan TD, Black D, Savady R, et al. Systemic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006; 24: 4011-9

71) Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2007; 14: 2281-8

72) Verwaal VJ, Ruth S, Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003; 21: 3737-43

73) 石原聡一郎, 青柳賀子, 端山 軍, 他. 腹膜播種の治療方針. 大腸癌Frontier. 2008; 1: 306-10

74) Blair SL, Chu DZ, Schwarz RE, et al. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol. 2001; 8: 632-7

75) 森 正一, 平井 孝. 肺切除の適応と術式. 外科. 2008; 70: 854-9

76) 板橋道朗, 廣澤知一郎, 番場嘉子, 他. 肺転移の治療方針. 大腸癌Frontier. 2008; 1: 292-6

77) 金光幸秀, 加藤知行, 平井 孝. 大腸癌肺転移に対する治療の現況—第55回大腸癌研究会アンケート結果—. 日本大腸肛門病会誌. 2004; 57: 121-31

78) McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg. 1992; 53: 780-5

79) Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg. 2005; 254-60

80) Koga R, Yamamoto J, Saiura A, et al. Surgical resection of pulmonary metastases from colorectal cancer: Four favourable prognostic factors. Jpn J Clin Oncol. 2006; 36: 643-8

81) Murata S, Moriya Y, Akasu T, et al. Resection both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer. 1998; 83: 1086-93

82) Kobayashi K, Kawamura M, Ishihara T. Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg. 1999; 118: 1090-6

83) Regnard JF, Grunenwald D, Spaggiari L, et al. Surgical treatment for hepatic and pulmonary metastases from colorectal cancer. Ann Thorac Surg. 1998; 66: 214-8

84) Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg. 2002; 124: 1007-13

85) Miller G, Biernacki P, Kemeny NE, et al. Outcomes after resection synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg. 2005; 205: 231-8

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp